Not only does a prostate cancer diagnosis bring uncertainty about the future, but it also presents the challenging task of deciding on the best treatment approach.

Breast cancer remains one of the most common cancers that affects women globally.

While the number of prostate cancers diagnosed each year declined sharply from 2007 to 2014, since then, the incidence rate has grown 3% per year overall and 5% per year for advanced-stage prostate cancer.